Abstract:Background: Axillary lymph node status has a guiding significance in the operative schemes. However, sensitivity and noninvasive for prediction of lymph node metastasis and survival of currently evidences is limited. This study aims to establish a deep learning algorithms of multi-parametric MRI radiomics for identifying lymph node metastasis and prognostic prediction, and investigate the relationship between the radiomics and tumor microenvironment in early stage breast cancer. Methods: RBC-01 is a multicentre, ambispective cohort study aims to assess multi-parametric MRI radiomics-based prediction model for identifying metastasis lymph nodes and prognostic prediction in early stage breast cancer. Patients are recruited from Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Sun Yat-sen University Cancer Center, Tungwah hospital of Sun Yat-sen University, and Shunde Hospital of Southern Medical University in China. Patients from Sun Yat-sen Memorial Hospital of Sun Yat-sen University are training cohort, and the independent validation cohort were built by patients from other centers. Eligible women could be aged from 18 to 75 years old with pathological diagnosis of early stage invasive breast cancer, without distant organ metastasis, and completed the breast MRI examination before therapy. PyRadiomics is used to extract patients’ breast cancer region, paratumor region, and axillary lymph nodes in multi-parametric MRI. To avoid MRI data heterogeneity bias, all MRI data are subjected to imaging normalization and resampled to the same resolution before feature extraction. The least absolute shrinkage and selection operator, random forest and supporting vector machine models are used to select the most useful radiomics characteristics from the training cohort, and then test by validation cohorts. The correlation between radiomics features and tumor microenvironment is also planned to investigate. Combined with independent risk factors, a radiomics nomogram was built with a multivariate logistic regression model. Decision curve analysis was performed with the combined training and validation set to estimate the clinical usefulness of the nomogram. The primary endpoint is disease-free survival. Secondary endpoints are lymph node metastasis prediction and overall survival. The trial is registered with ClinicalTrials.gov, number NCT04003558, and Chinese Clinical Trail Registry, number ChiCTR1900024020. Citation Format: Herui Yao, Yujie Tan, Yunfang Yu, Chuanmiao Xie, Qiugen Hu, Jie Ouyang, Chenchen Li, Kai Chen, Nian Lu, Xiaohong Li, Rong Zhang, Jiafan Ma, Ying Wang, Jianli Zhao. Radiomics of multi-parametric MRI associated with axillary lymph node metastasis and prognostic in patients with breast cancer: A multicenter RBC-001 study [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr OT3-02-02.

Single- and multi-site radiomics may improve overall survival prediction for patients with metastatic lung adenocarcinoma

Enhancing Immunotherapy Response Prediction in Metastatic Lung Adenocarcinoma: Leveraging Shallow and Deep Learning with CT-Based Radiomics across Single and Multiple Tumor Sites

Enhancing Survival Outcome Predictions in Metastatic Non-Small Cell Lung Cancer Through PET Radiomics Analysis

Metastatic Lung Adenocarcinomas: Development and Evaluation of Radiomic-Based Methods to Measure Baseline Intra-Patient Inter-Tumor Lesion Heterogeneity

Prediction of brain metastases progression and overall survival in patients with metastatic non-small cell lung cancer treated by immune checkpoint inhibitors using a radiomic model.

Risk stratification and overall survival prediction in extensive stage small cell lung cancer after chemotherapy with immunotherapy based on CT radiomics

Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis

Clinical-Radiomics Model Enhancing Prediction of Occult Nodal Metastasis in Ct1a-Bn0m0-stage Lung Adenocarcinoma: A Multi-center Study

PET/CT radiomics and machine learning enable non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma

Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer

Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study

Radiotranscriptomics of non-small cell lung carcinoma for assessing high-level clinical outcomes using a machine learning-derived multi-modal signature

Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics

Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease

Prognostic Value of 18F-FDG PET/CT Radiomic Model Based on Primary Tumor in Patients with Non-Small Cell Lung Cancer: A Large Single-Center Cohort Study

Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer

Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancer

Radiomics of multi-parametric MRI associated with axillary lymph node metastasis and prognostic in patients with breast cancer: A multicenter RBC-001 study

CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma

Identification of a rank-based radiomic signature with individualized prognostic value for lung adenocarcinoma in a multi-cohort study